CC / The Chemours Company - SEC-arkivering, Årsberetning, Fuldmagtserklæring

CONFLICT MINERALS REPORT THE CHEMOURS COMPANY For the Reporting Period from January 1, 2025 to December 31, 2025

Exhibit 1.01 CONFLICT MINERALS REPORT THE CHEMOURS COMPANY For the Reporting Period from January 1, 2025 to December 31, 2025 This Conflict Minerals Report (the “Report”) of The Chemours Company (“Chemours,” or the “Company”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities and Exchange Act of 1934, as amended, for the reporting period from January

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incorporation) File Number) Identification No.) 1007 Market Street Wilmington, Delaware 19801 (Address of principal executi

Table 1: Newly Registered Securities

Calculation of Filing Fee Tables S-8 Chemours Co Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0.

EXPLANATORY NOTE PART I PART II ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE. ITEM 4. DESCRIPTION OF SECURITIES. ITEM 5. INTERESTS OF NAMED EXPERTS AND COUNSEL. ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS. ITEM 7. EXEMPTION FROM REGISTRAT

As filed with the U.S. Securities and Exchange Commission on May 6, 2026. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 The Chemours Company (Exact name of registrant as specified in its charter) Delaware 46-4845564 (State or other jurisdiction of incorporation or organization) (I.R.S.

MINE SAFETY DISCLOSURES

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 5, 2026 Date of Report (Date of Earliest Event Reported) The Chemours Company (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 5, 2026 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incor

The Chemours Company Reports First Quarter Results

EXHIBIT 99.1 The Chemours Company Reports First Quarter Results Wilmington, Del., May 5, 2026 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the first quarter 2026.

FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Speci

THE CHEMOURS COMPANY 2026 EQUITY AND INCENTIVE PLAN

Exhibit 10.1 THE CHEMOURS COMPANY 2026 EQUITY AND INCENTIVE PLAN SECTION 1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS The name of the plan is The Chemours Company 2026 Equity and Incentive Plan (as amended from time to time, the “Plan”). The purpose of the Plan is to encourage and enable the officers, employees, Non-Employee Directors and Consultants of The Chemours Company, a Delaware corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 24, 2026 Date of Report (Date of Earliest Event Reported) The Chemours Compan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 24, 2026 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 12, 2026 Date of Report (Date of Earliest Event Reported) The Chemours Compan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 12, 2026 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

ARTICLE 1 DEFINITIONS ARTICLE 2 GENERAL TERMS AND CONDITIONS OF THE NOTES ARTICLE 3 SUBSIDIARY GUARANTEES ARTICLE 4 ADDITIONAL COVENANTS ARTICLE 5 DEFAULTS AND REMEDIES ARTICLE 6 CONCERNING THE TRUSTEE ARTICLE 7 SUPPLEMENTAL INDENTURES ARTICLE 8 CONS

Exhibit 4.2 FOURTH SUPPLEMENTAL INDENTURE Dated as of March 12, 2026 among THE CHEMOURS COMPANY, as Issuer, THE SUBSIDIARY GUARANTORS PARTY HERETO, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee, to the Indenture, dated as of November 27, 2020, relating to Senior Debt Securities Table of Contents Page ARTICLE 1 DEFINITIONS 1 SECTION 1.1 Definition of Terms. 1 SECTION 1.2 Limited Condition Tr

The Chemours Company Announces Completion of Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034

EXHIBIT 99.1 The Chemours Company Announces Completion of Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034 Wilmington, Del., March 12, 2026 - The Chemours Company (Chemours) (NYSE: CC) today announced it completed its previously announced private offering of $700,000,000 in aggregate principal amount of 7.875% senior unsecured notes due 2034 (th

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

ARS

2025 ANNUAL REPORTI am extremely proud of the significant strategic progress Chemours made in 2025.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 26, 2026 Date of Report (Date of Earliest Event Reported) The Chemours Com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 26, 2026 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

The Chemours Company Announces Upsizing and Pricing of Private Offering of $700,000,000 of 7.875% Senior Notes Due 2034

EXHIBIT 99.2 The Chemours Company Announces Upsizing and Pricing of Private Offering of $700,000,000 of 7.875% Senior Notes Due 2034 WILMINGTON, Del., February 26, 2026 - The Chemours Company (Chemours) (NYSE: CC) today announced the pricing of its previously announced private offering of $700,000,000 aggregate principal amount of new 7.875% senior notes due 2034 (the “Notes”). The offering size w

The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2034

EXHIBIT 99.1 The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2034 Wilmington, Del., February 26, 2026 – The Chemours Company (“Chemours”) (NYSE: CC) today announced that it intends to offer $600,000,000 aggregate principal amount of new senior notes due 2034 (the “Notes”), subject to market and other conditions. The Notes will be senior unsecured obligations of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified

SUBSIDIARIES OF THE REGISTRANT

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Name Organized Under Laws Of 2463297 Ontario Limited Canada Chemours Belgium BVBA Belgium Chemours Deutschland GmbH Germany Chemours France SAS France Chemours Hong Kong Holding Limited Hong Kong Chemours International Operations Sàrl Switzerland Chemours Italy S.

MINE SAFETY DISCLOSURES

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

LIST OF GUARANTOR SUBSIDIARIES

Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of December 31, 2025, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 5.

The Chemours Company Reports Fourth Quarter and Full Year 2025 Results

EXHIBIT 99.1 The Chemours Company Reports Fourth Quarter and Full Year 2025 Results Wilmington, Del., February 19, 2026 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results fo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 19, 2026 Date of Report (Date of Earliest Event Reported) The Chemours Com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 19, 2026 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

************************ Real Estate Sale and Purchase Agreement Lai Wen-Hsiang The Chemours (Taiwan) Company Limited _15th January_, 2026

EXHIBIT 10.4 ************************ 不動產買賣契約書 Real Estate Sale and Purchase Agreement 賴文祥 Lai Wen-Hsiang 及 and 台灣科慕股份有限公司 The Chemours (Taiwan) Company Limited 2026年01月15日 15th January, 2026 EXHIBIT 10.4 本不動產買賣契約書（以下簡稱「本契約」）係由 This Real Estate Sale and Purchase Agreement (hereinafter referred to as the “Agreement”) is entered into by and between: (1) 台灣科慕股份有限公司（依據中華民國法律設立，址設於臺北市松山區敦化北路167號7樓，以下簡稱

************************ Real Estate Sale and Purchase Agreement Century Iron And Steel Industrial Co., Ltd. The Chemours (Taiwan) Company Limited _15th January_, 2026

EXHIBIT 10.2 ************************ 不動產買賣契約書 Real Estate Sale and Purchase Agreement 世紀鋼鐵結構股份有限公司 Century Iron And Steel Industrial Co., Ltd. 及 and 台灣科慕股份有限公司 The Chemours (Taiwan) Company Limited 2026年01月15日 15th January, 2026 EXHIBIT 10.2 本不動產買賣契約書（以下簡稱「本契約」）係由 This Real Estate Sale and Purchase Agreement (hereinafter referred to as the “Agreement”) is entered into by and between: (1) 台灣科慕股份有限

************************ Real Estate Sale and Purchase Agreement Century Wind Power Co., Ltd. The Chemours (Taiwan) Company Limited _15th January_, 2026

EXHIBIT 10.1 ************************ 不動產買賣契約書 Real Estate Sale and Purchase Agreement 世紀離岸風電設備股份有限公司 Century Wind Power Co., Ltd. 及 and 台灣科慕股份有限公司 The Chemours (Taiwan) Company Limited 2026年01月15日 15th January, 2026 EXHIBIT 10.1 本不動產買賣契約書（以下簡稱「本契約」）係由 This Real Estate Sale and Purchase Agreement (hereinafter referred to as the “Agreement”) is entered into by and between: (1) 台灣科慕股份有限公司（依據中華民國法律設立

************************ Real Estate Sale and Purchase Agreement Century Huaxin Wind Energy Co., Ltd. The Chemours (Taiwan) Company Limited _15th January_, 2026

EXHIBIT 10.3 ************************ 不動產買賣契約書 Real Estate Sale and Purchase Agreement 世紀樺欣風能股份有限公司 Century Huaxin Wind Energy Co., Ltd. 及 and 台灣科慕股份有限公司 The Chemours (Taiwan) Company Limited 2026年01月15日 15th January, 2026 EXHIBIT 10.3 本不動產買賣契約書（以下簡稱「本契約」）係由 This Real Estate Sale and Purchase Agreement (hereinafter referred to as the “Agreement”) is entered into by and between: (1) 台灣科慕股份有限公司（依據中華

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 January 15, 2026 Date of Report (Date of Earliest Event Reported) The Chemours Comp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 January 15, 2026 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan

EXHIBIT 99.1 The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan Wilmington, Del., January 15, 2026 – The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today signed a set of definitive agre

The Chemours Company Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures (Unaudited) (Dollars in millions) GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation GAAP Net Leverag

EXHIBIT 99.2 Q3 2025 Financial Prepared Remarks Comments made in these remarks, as well as in the supplemental information provided on our website, contain forward-looking statements that involve risks and uncertainties as described in The Chemours Company's (the "Company") SEC filings. These forward-looking statements are not guarantees of future performance and are based on certain assumptions a

LIST OF GUARANTOR SUBSIDIARIES

Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of September 30, 2025, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 5.

MINE SAFETY DISCLOSURES

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as S

The Chemours Company Reports Third Quarter 2025 Results

EXHIBIT 99.1 The Chemours Company Reports Third Quarter 2025 Results Wilmington, Del., November 6, 2025 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the third quar

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 6, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Comp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 6, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

EX-10.1

EXHIBIT 10.1 the chemours company executive severance policy The Chemours Company Executive Severance Policy (the “Policy”), is approved by the Board of Directors (the “Board”) of The Chemours Company (the “Company”) effective as of October 28, 2025 (the “Effective Date”). SECTION 1 PURPOSE The purpose of this Policy is to promote retention and stability in the senior management of the Company by

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 28, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Comp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 28, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

Preamble Art. 1 Offer for purchase of receivables Art. 2 Acceptance of the purchase offer, obligation to accept Art. 3 Purchase Price Art. 4 Type of procedure – Balance Reconciliation System, undisclosed Inhouse Procedure, revocation Art. 5 Retention

EXHIBIT 99.1 Receivables Purchase Program between Chemours Deutschland GmbH Dornhofstraße 34 63263 Neu-Isenburg Germany and Chemours International Operations Sarl Route du Nant-d’Avril 150 1217 Meyrin Switzerland and Chemours Netherlands BV Baanhoekweg 22 3313 LA Dordrecht Netherlands Dordrecht, NL trade register no. 54013445 and Chemours International BV Baanhoekweg 22 3313 LA Dordrecht Netherlan

Fiscal Quarter Senior Secured Net Leverage Ratio March 31, 2025 2.75 to 1.00 June 30, 2025 2.75 to 1.00 September 30, 2025 2.75 to 1.00 December 31, 2025 2.75 to 1.00 March 31, 2026 2.75 to 1.00 June 30, 2026 2.50 to 1.00 September 30, 2026 2.50 to 1

EXHIBIT 10.1 [EXECUTION VERSION] AMENDMENT NO. 4 dated as of October 15, 2025 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), the other LOAN PARTIES party hereto, the LENDERS and ISSUING BANKS party hereto and JPMORGAN CHASE BANK, N.A., as administrative agent (in such capacity, the “Administrative Agent”), to the Second Amended and Restated Credit Agreemen

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 13, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Comp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 13, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 September 2, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 September 2, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 29, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Compa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 29, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of I

FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specif

The Chemours Company Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures (Unaudited) (Dollars in millions) GAAP Net (Loss) Income Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation GAAP Net Leverag

EXHIBIT 99.2 Q2 2025 Financial Prepared Remarks Comments made in these remarks, as well as in the supplemental information provided on our website, contain forward-looking statements that involve risks and uncertainties as described in The Chemours Company's (the "Company") SEC filings. These forward-looking statements are not guarantees of future performance and are based on certain assumptions a

Mine Safety Disclosures.

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

The Chemours Company Reports Second Quarter 2025 Results

EXHIBIT 99.1 The Chemours Company Reports Second Quarter 2025 Results Wilmington, Del., August 5, 2025 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the second quar

List of Guarantor Subsidiaries

Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of June 30, 2025, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 5.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 5, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Compan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 5, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 4, 2025 (August 3, 2025) Date of Report (Date of Earliest Event Reported) Th

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 4, 2025 (August 3, 2025) Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.

10.2 PFAS Insurance Proceeds Memorandum of Understanding, dated August 3, 2025, by and among The Chemours Company, Corteva, Inc. and DuPont de Nemours, Inc.*

Exhibit 10.2 [Execution Version] PFAS INSURANCE PROCEEDS MEMORANDUM OF UNDERSTANDING This binding memorandum of understanding (together with the exhibits hereto, this “MOU”) is made and entered into this 3rd day of August, 2025, by and among The Chemours Company (“Chemours”), Corteva, Inc. (“Corteva”) and DuPont de Nemours, Inc. (f/k/a DowDuPont Inc.) (“DuPont”). “Party” or “Parties” means Chemour

10.1 Form of Judicial Consent Order, dated August 3, 2025 and Exhibit A*

Exhibit 10.1 MATTHEW J. PLATKIN ATTORNEY GENERAL OF NEW JERSEY R.J. Hughes Justice Complex 25 Market Street, P.O. Box 093 Trenton, New Jersey 08625-0093 Attorney for Plaintiffs By: Gwen Farley Deputy Attorney General Attorney ID No. 000081999 Ph. (609) 376-2740 [email protected] United States District Court District of New Jersey NEW JERSEY DEPARTMENT OF ENVIRONMENTAL PROTECTION; THE COMMI

Chemours, DuPont and Corteva Reach Agreement with the State of New Jersey to Comprehensively Resolve All Environmental Claims Including PFAS

Exhibit 99.1 Chemours, DuPont and Corteva Reach Agreement with the State of New Jersey to Comprehensively Resolve All Environmental Claims Including PFAS · Resolves all environmental claims, including those related to PFAS, across four current and former operating sites and all statewide PFAS claims, including those related to aqueous film forming foam (“AFFF”). · Settlement payments over 25 years

Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD.

Exhibit 1.01 CONFLICT MINERALS REPORT THE CHEMOURS COMPANY For the Reporting Period from January 1, 2024 to December 31, 2024 This Conflict Minerals Report (the “Report”) of The Chemours Company (“Chemours,” or the “Company”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities and Exchange Act of 1934, as amended, for the reporting period from January

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incorporation) File Number) Identification No.) 1007 Market Street Wilmington, Delaware 19801 (Address of principal executi

Mine Safety Disclosures.

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Speci

The Chemours Company Reports First Quarter 2025 Results

EXHIBIT 99.1 The Chemours Company Reports First Quarter 2025 Results Wilmington, Del., May 6, 2025 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the first quarter 2

Amendment No. 3, Dated as of May 2, 2025, among The Chemours Company, the other Loan Parties, and the Lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent, to the Second Amended and Restated Credit Agreement dated as of August 18, 2023.

EXECUTION VERSION EXHIBIT 10.1 AMENDMENT NO. 3 dated as of May 2, 2025 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), the other LOAN PARTIES party hereto, the LENDERS and ISSUING BANKS party hereto and JPMORGAN CHASE BANK, N.A. (in its individual capacity, “JPMorgan”), as administrative agent (in such capacity, the “Administrative Agent”), to the Second Am

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 6, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 6, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incor

List of Guarantor Subsidiaries

Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of March 31, 2025, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 5.

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 22, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ De

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Def

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ De

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Def

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 28, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT Dated as of March 9, 2020 by and among THE CHEMOURS COMPANY AR, LLC, as Seller, THE PERSONS FROM TIME TO TIME PARTY HERETO, as Purchasers and as Group Agents, THE TORONTO-DOMINION BANK, as Administr

EXHIBIT 99.2 EXECUTION VERSION EXHIBIT A TO THE THIRDFOURTH AMENDMENT, DATED AS OF MARCH 2328, 20232025 AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT Dated as of March 9, 2020 by and among THE CHEMOURS COMPANY AR, LLC, as Seller, THE PERSONS FROM TIME TO TIME PARTY HERETO, as Purchasers and as Group Agents, THE TORONTO-DOMINION BANK, as Administrative Agent, THE TORONTO-DOMINION BANK, as LC

FOURTH AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT

EXHIBIT 99.1 FOURTH AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT This FOURTH AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT (this “Amendment”), dated as of March 28, 2025, is among THE CHEMOURS COMPANY AR, LLC, as Seller (in such capacity, the “Seller”), THE CHEMOURS COMPANY FC, LLC (“Chemours”), as initial Servicer (in such capacity, the “Servicer”), RELIANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Def

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule

ARS

2024 ANNUAL REPORT THE CHEMOURS COMPANYIt is my privilege to write to you on behalf of our leadership team to share Chemours’ progress in 2024.

Shareholder Proposal Number 5 on The Chemours Company’s 2025 Proxy Statement: ADOPT A POLICY TO ASSESS BIODIVERSITY IMPACTS PRIOR TO COMMENCING MINING OPERATIONS The Chemours Company Symbol: CC Filed by: Green Century Capital Management, Inc.

NAME OF REGISTRANT: The Chemours Company NAME OF PERSON RELYING ON EXEMPTION: Green Century Capital Management, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 9, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 9, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified

Insider Trading Policy

EXHIBIT 19 The Chemours Company Insider Trading Policy 1. Background The Chemours Company (“Chemours,” or the “Company”) and its directors, officers and employees worldwide must act in a manner that does not misuse material financial or other information that has not been publicly disclosed. Failure to do so impacts our integrity. Also in some jurisdictions, including the United States, insider tr

Mine Safety Disclosures.

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

Amendment No. 1, dated as of November 29, 2024, among The Chemours Company, the other Loan Parties, and the Lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent, to the Second Amended and Restated Credit Agreement dated as of August 18, 2023.

EXHIBIT 10.15 AMENDMENT NO. 1 dated as of November 29, 2024 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), the other LOAN PARTIES party hereto, the LENDERS party hereto and JPMORGAN CHASE BANK, N.A. (“JPMorgan”), as administrative agent (in such capacity, the “Administrative Agent”), to the Second Amended and Restated Credit Agreement dated as of August 18

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 18, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 13, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

Subsidiaries of the Registrant.

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Name Organized Under Laws Of 2463297 Ontario Limited Canada Chemours Belgium BVBA Belgium Chemours Deutschland GmbH Germany Chemours France SAS France Chemours Hong Kong Holding Limited Hong Kong Chemours International Operations Sàrl Switzerland Chemours Italy S.

The Chemours Company Reports Fourth Quarter and Full Year 2024 Results

EXHIBIT 99.1 The Chemours Company Reports Fourth Quarter and Full Year 2024 Results Wilmington, Del., February 18, 2025 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results fo

List of Guarantor Subsidiaries.

Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of December 31, 2024, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 5.

Amendment No. 2, dated as of December 13, 2024, among The Chemours Company, the other Loan Parties, and the Lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent, to the Second Amended and Restated Credit Agreement dated as of August 18, 2023.

EXHIBIT 10.16 AMENDMENT NO. 2 dated as of December 13, 2024 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), the other LOAN PARTIES party hereto, the LENDERS party hereto and JPMORGAN CHASE BANK, N.A. (“JPMorgan”), as administrative agent (in such capacity, the “Administrative Agent”), to the Second Amended and Restated Credit Agreement dated as of August 18

Chemours Appoints Leslie M. Turner to its Board of Directors Former Hershey and Coca-Cola Executive adds extensive legal, governance, and policy expertise to Chemours’ Board of Directors

EXHIBIT 99.1 Chemours Appoints Leslie M. Turner to its Board of Directors Former Hershey and Coca-Cola Executive adds extensive legal, governance, and policy expertise to Chemours’ Board of Directors Wilmington, Del., February 11, 2025 – The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 10, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

EX-99

Exhibit 99 Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G.

EX-99

EX-99 2 exhibit99.txt Exhibit 99 Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management

Chemours Appoints Google Executive Joseph Kava to its Board of Directors Board addition brings strong tech industry expertise to advance the company’s Pathway to Thrive business strategy

EXHIBIT 99.1 Chemours Appoints Google Executive Joseph Kava to its Board of Directors Board addition brings strong tech industry expertise to advance the company’s Pathway to Thrive business strategy Wilmington, Del., January 7, 2025 – The Chemours Company (Chemours) (NYSE: CC), a global leader in delivering innovative performance chemistry, today announced the appointment of Joseph (Joe) Kava to

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 January 3, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of I

Amendment No. 2, dated as of December 13, 2024, among The Chemours Company, the other Loan Parties, and the Lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent, to the Second Amended and Restated Credit Agreement dated as of August 18, 2023

EXHIBIT 10.1 AMENDMENT NO. 2 dated as of December 13, 2024 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), the other LOAN PARTIES party hereto, the LENDERS party hereto and JPMORGAN CHASE BANK, N.A. (“JPMorgan”), as administrative agent (in such capacity, the “Administrative Agent”), to the Second Amended and Restated Credit Agreement dated as of August 18,

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 December 13, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

The Chemours Company Announces Completion of Euro denominated Term Loan Repricing

EXHIBIT 99.1 The Chemours Company Announces Completion of Euro denominated Term Loan Repricing Wilmington, Del., December 13, 2024 - The Chemours Company (Chemours) (NYSE: CC) today announced the successful repricing of its Tranche B-3 Euro denominated Term Loan under its senior secured term loan facility due in August 2028. The Second Amendment reduces the applicable margin in respect of the Comp

Third Supplemental Indenture, dated as of November 27, 2024, among The Chemours Company, the guarantors party thereto and Deutsche Bank Trust Company Americas, as trustee

EXHIBIT 4.1 THIRD SUPPLEMENTAL INDENTURE Dated as of November 27, 2024 among THE CHEMOURS COMPANY, as Issuer, THE SUBSIDIARY GUARANTORS PARTY HERETO, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee, to the Indenture, dated as of November 27, 2020, relating to Senior Debt Securities EXHIBIT 4.1 Table of Contents Page ARTICLE 1 DEFINITIONS 1 SECTION 1.1 Definition of Terms. 1 SECTION 1.2 Limite

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 27, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer

Amendment No. 1, dated as of November 29, 2024, among The Chemours Company, the other Loan Parties, and the Lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent, to the Second Amended and Restated Credit Agreement dated as of August 18, 2023

EXHIBIT 10.1 AMENDMENT NO. 1 dated as of November 29, 2024 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), the other LOAN PARTIES party hereto, the LENDERS party hereto and JPMORGAN CHASE BANK, N.A. (“JPMorgan”), as administrative agent (in such capacity, the “Administrative Agent”), to the Second Amended and Restated Credit Agreement dated as of August 18,

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 29, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

The Chemours Company Announces Completion of U.S. Dollar-denominated Term Loan Repricing

EXHIBIT 99.1 The Chemours Company Announces Completion of U.S. Dollar-denominated Term Loan Repricing Wilmington, Del., November 29, 2024 - The Chemours Company (Chemours) (NYSE: CC) today announced the successful repricing of its Tranche B-3 U.S. Dollar-denominated Term Loan under its senior secured term loan facility due in August 2028. The repricing reduces the applicable margin in respect of t

The Chemours Company Announces Completion of Private Offering of $600,000,000 Aggregate Principal Amount of 8.000% Senior Unsecured Notes Due 2033

EXHIBIT 99.1 The Chemours Company Announces Completion of Private Offering of $600,000,000 Aggregate Principal Amount of 8.000% Senior Unsecured Notes Due 2033 Wilmington, Del., November 27, 2024 - The Chemours Company (Chemours) (NYSE: CC) today announced it completed its previously announced private offering of $600,000,000 in aggregate principal amount of 8.000% senior unsecured notes due 2033

Third Supplemental Indenture, dated as of November 27, 2024, among The Chemours Company, the guarantors party thereto and Deutsche Bank Trust Company Americas, as trustee

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 27, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 13, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2033

EXHIBIT 99.1 The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2033 Wilmington, Del., November 13, 2024 – The Chemours Company (Chemours) (NYSE: CC) today announced that it intends to offer $600,000,000 aggregate principal amount of new senior notes due 2033 (the “Notes”), subject to market and other conditions. The Notes will be senior unsecured obligations of Ch

The Chemours Company Announces Pricing of Private Offering of $600,000,000 of 8.000% Senior Notes Due 2033

EXHIBIT 99.2 The Chemours Company Announces Pricing of Private Offering of $600,000,000 of 8.000% Senior Notes Due 2033 WILMINGTON, Del., November 13, 2024 - The Chemours Company (Chemours) (NYSE: CC) today announced the pricing of its previously announced private offering of $600,000,000 aggregate principal amount of new 8.000% senior notes due 2033 (the “Notes”). The Notes will bear interest at

CC / The Chemours Company / FMR LLC Passive Investment

SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.11 CHEMOURS CO COMMON STOCK Cusip #163851108 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #163851108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 17,291,941 Item 6: 0 Item 7: 18,028,524 Item 8: 0 Item 9: 18,0

Third Quarter 2024 Highlights Generated $1.5B in Net Sales and $208M in Adjusted EBITDA Provided Refreshed Three-Year Corporate Strategy Continued strong adoption of Opteon™ Refrigerants in TSS with 21% YoY growth TT Adjusted EBITDA up 23% YoY, drive

Third Quarter 2024 Earnings Presentation November 4, 2024 Exhibit 99.2 Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events ba

The Chemours Company Reports Third Quarter 2024 Results and Outlines Refreshed Corporate Strategy

EXHIBIT 99.1 The Chemours Company Reports Third Quarter 2024 Results and Outlines Refreshed Corporate Strategy Wilmington, Del., November 4, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global leader in delivering innovative performance chemistry through Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), tod

Mine Safety Disclosures.

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

List of Guarantor Subsidiaries

Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of September 30, 2024, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 4, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 14, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Compa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 14, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of I

The Chemours CompanyInvestor Presentation August 2024

The Chemours Company Investor Presentation August 2024 Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties.

The Chemours Company Reports Second Quarter 2024 Results

EXHIBIT 99.1 The Chemours Company Reports Second Quarter 2024 Results Wilmington, Del., August 1, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global leader in delivering innovative performance chemistry through Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 1, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

List of Guarantor Subsidiaries

Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of June 30, 2024, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4.

Mine Safety Disclosures.

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specif

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 23, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc

Chemours Names Tony Satterthwaite to Board of Directors

EXHIBIT 99.1 Chemours Names Tony Satterthwaite to Board of Directors Wilmington, Del., June 13, 2024 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Livingston “Tony” Satterthwaite to its Board of Directors, effec

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 12, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 31, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 31, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco

Chemours Appoints Shane Hostetter as Chief Financial Officer

EXHIBIT 99.1 Chemours Appoints Shane Hostetter as Chief Financial Officer Wilmington, Del., June 5, 2024 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Shane Hostetter as Chief Financial Officer (CFO) effective J

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 31, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 31, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco

The Chemours Company Temporarily Pauses Titanium Dioxide Production at Altamira, Mexico Site Amid Severe Regional Drought

EXHIBIT 99.1 The Chemours Company Temporarily Pauses Titanium Dioxide Production at Altamira, Mexico Site Amid Severe Regional Drought Wilmington, Del., May 31, 2024 – As a result of the severe drought impacting much of Mexico, The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company, today announced it is complying with a request from the government to temporarily minimize water i

Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD.

Exhibit 1.01 CONFLICT MINERALS REPORT THE CHEMOURS COMPANY For the Reporting Period from January 1, 2023 to December 31, 2023 This Conflict Minerals Report (the “Report”) of The Chemours Company (“Chemours,” or the “Company”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities and Exchange Act of 1934, as amended, for the reporting period from January

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report The Chemours Company (Exact Name of Registrant as Specified in Its Charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incorporation) File Number) Identification No.) 1007 Market Street Wilmington, Delaware 19801 (Address of principal executi

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 21, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant ☒     Filed by a Party other than the Registrant ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 30, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

The Chemours Company Reports First Quarter 2024 Results

EXHIBIT 99.1 The Chemours Company Reports First Quarter 2024 Results Wilmington, Del., April 30, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the first quarte

List of Guarantor Subsidiaries

Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of March 31, 2024, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4.

Mine Safety Disclosures.

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Speci

Separation and Release Agreement, dated as of April 23, 2024, by and between The Chemours Company and Jonathan S. Lock

Exhibit 10.1 EXECUTION COPY SEPARATION AND RELEASE AGREEMENT THIS SEPARATION AND RELEASE AGREEMENT (this “Agreement”), dated as of April 23, 2024, is by and between The Chemours Company (the “Company”), and Jonathan S. Lock (“Executive”). The Company and Executive are hereinafter referred to as the “Parties”. WHEREAS, Executive has been employed by the Company as its Senior Vice President and Chie

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 23, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction of Incorporation) (Commission File

ARS

THE CHEMOURS COMPANY 2023 ANNU AL REP OR TDear Chemours Stakeholders At Chemours, everything we do must be underpinned by our core values.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant ☒Filed by a Party other than the Registran

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant ☒Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin

COURTESY PDF

2024 NOTICE OF ANNUAL SHAREHOLDERS MEETING AND PROXY STATEMENT1007MarketStreet Wilmington,Delaware19801 April 11, 2024 Dear Fellow Shareholders: Thank you for your continued investment in Chemours.

©2024, AlphaSense, Inc. All Rights Reserved. AlphaSense is a service mark of AlphaSense, Inc. All other trademarks mentioned belong to their respective owners.

Exhibit 99.1 Transcript – The Chemours Company, Q4 2023 Earnings Call, Mar 28, 2024 Ú Call Participants EXECUTIVES Brandon Ontjes Vice President of FP&A and Investor Relations Denise M. Dignam President & CEO Matthew S. Abbott Interim CFO and Principal Financial & Accounting Officer ANALYSTS Arun Shankar Viswanathan RBC Capital Markets, Research Division Hassan Ijaz Ahmed Alembic Global Advisors J

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 28, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction of Incorporation) (Commission File

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 27, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

Chemours Announces Completion of Planned Procedures by the Audit Committee with Respect to Internal Review Discloses Material Weaknesses and Remediation Plan

EXHIBIT 99.1 Chemours Announces Completion of Planned Procedures by the Audit Committee with Respect to Internal Review Discloses Material Weaknesses and Remediation Plan Wilmington, Del., March 27, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”),

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 27, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

The Chemours Company Reports Fourth Quarter and Full Year 2023 Results

EXHIBIT 99.1 The Chemours Company Reports Fourth Quarter and Full Year 2023 Results Wilmington, Del., March 27, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for t

Special Employment and Separation Agreement and Release between Susan Kelliher and the Company, dated as of September 25, 2023.

EXHIBIT 10.43 AGREEMENT AND RELEASE This Special Employment and Separation Agreement and Release ("Release" or “Agreement”) is made and entered into this 25th day of September 2023 by and between and The Chemours Company (“Chemours” or "Employer" or “Company”) and Susan Kelliher ("Employee"), in connection with Employee's change of role effective October 1, 2023 (the “Effective Date”) and separati

Incentive-Based Compensation Clawback Policy for Executive Officers.

EXHIBIT 97 The Chemours Company Incentive-Based Compensation Clawback Policy for Executive Officers (Effective on October 25, 2023) This Policy covers each current and former “Executive Officer,” within the meaning of Rule 10D-1 adopted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Section 303A.

Amendment to the Special Employment and Separation Agreement and Release between David C. Shelton and the Company, dated as of December 19, 2023.

EXHIBIT 10.41 AMENDMENT TO SPECIAL EMPLOYMENT AND SEPARATION AGREEMENT AND RELEASE This Amendment to the Special Employment and Separation Agreement and Release (“Amendment”), is dated as of December 19, 2023 (the “Effective Date”), and is made by and between THE CHEMOURS COMPANY (“Chemours” or “Employer” or “Company”), and DAVID C. SHELTON (“Shelton” or “Employee”). Chemours and Shelton are somet

Mine Safety Disclosures.

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

List of Guarantor Subsidiaries.

Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of December 31, 2023, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified

Subsidiaries of the Registrant.

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Name Organized Under Laws Of 2463297 Ontario Limited Canada Chemours Belgium BVBA Belgium Chemours Chemicals Rus Russia Chemours Deutschland GmbH Germany Chemours France SAS France Chemours Hong Kong Holding Limited Hong Kong Chemours International Operations Sàrl Switzerland Chemours Italy S.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 26, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction of Incorporation) (Commission File

Chemours Announces Dates for Fourth Quarter 2023 Earnings Release, 2023 Form 10-K Filing and Webcast Conference Call

Exhibit 99.1 Chemours Announces Dates for Fourth Quarter 2023 Earnings Release, 2023 Form 10-K Filing and Webcast Conference Call Wilmington, Del., March 26, 2024 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) today announced that the Company currently expects to issue its fourth quarter and full year 2023 financial results and file its Annual Report on Form 10-K for the year ende

Separation and Release Agreement, dated as of March 22, 2024, by and between The Chemours Company and Mark E. Newman

EX-10.1 Exhibit 10.1 EXECUTION COPY SEPARATION AND RELEASE AGREEMENT THIS SEPARATION AND RELEASE AGREEMENT (this “Agreement”), dated as of March 22, 2024, is by and between The Chemours Company (the “Company”), and Mark E. Newman (“Executive”). The Company and Executive are hereinafter referred to as the “Parties”. WHEREAS, Executive has been employed by the Company as its President and Chief Exec

Chemours Announces Appointment of Denise Dignam as President and Chief Executive Officer of the Company

EX-99.1 Exhibit 99.1 Chemours Announces Appointment of Denise Dignam as President and Chief Executive Officer of the Company Wilmington, Del., March 22, 2024 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Denise

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 22, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Compan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 22, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction of Incorporation) (Commission File

Chemours Receives NYSE Notice Regarding Delayed Form 10-K Filing

Exhibit 99.1 Chemours Receives NYSE Notice Regarding Delayed Form 10-K Filing Wilmington, Del., March 18, 2024 – On March 18, 2024, The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) received notice from the New York Stock Exchange (the “NYSE”) that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Annual Report on Form

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 18, 2024 Date of Report (Date of earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction Of Incorporation) (Commission File

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 6, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction Of Incorporation) (Commission File

Chemours Provides update on Internal Review

Exhibit 99.1 Chemours Provides update on Internal Review Wilmington, Del., March 6, 2024 (Business Wire) – As previously disclosed, the Audit Committee of the Board of Directors of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), with the assistance of independent outside counsel, has been overseeing an internal review. The review relates to an anonymous report made to the Chemours E

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 28, 2024 Date of Report (Date of earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction Of Incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One)  ☒ Form 10-K  ☐ Form 20-F  ☐ Form 11-K  ☐ Form 10-Q ☐ Form 10-D  ☐ Form N-SAR  ☐ Form N-CSR For Period Ended: December 31, 202

Commission File Number: 001-36794 CUSIP Number: 163851108 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

February 28, 2024

EX-99.1 Exhibit 99.1 February 28, 2024 WILMINGTON, Del.–(BUSINESS WIRE) – The Board of Directors of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) has appointed Denise Dignam as the Interim Chief Executive Officer and Matt Abbott as the Interim Chief Financial Officer (principal financial and accounting officer). Ms. Dignam joined Chemours in 2015 and has served as our President – T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 29, 2024 Date of Report (Date of earliest Event Reported) The Chemours Com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 29, 2024 Date of Report (Date of earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction Of Incorporation) (Commission F

Chemours Announces Changes to its Board of Directors Pamela Fletcher appointed as director; Sandra Phillips Rogers will not stand for reelection

EXHIBIT 99.1 Chemours Announces Changes to its Board of Directors Pamela Fletcher appointed as director; Sandra Phillips Rogers will not stand for reelection Wilmington, Del., February 16, 2024 – The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today an

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 12, 2024 (November 17, 2023) Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commissi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 12, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 13, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

Chemours Reschedules Earnings Release and Conference Call

EXHIBIT 99.1 Chemours Reschedules Earnings Release and Conference Call Wilmington, Del., February 13, 2024 – The Chemours Company (“Chemours”or “the Company") (NYSE: CC) today announced that it has postponed the release of its financial results and conference call related to the fourth quarter and full year ended December 31, 2023, which had previously been scheduled for February 14, 2024 and Febr

CC / The Chemours Company / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0590-chemourscothe.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Chemours Co/The Title of Class of Securities: Common Stock CUSIP Number: 163851108 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the r

CC / The Chemours Company / FMR LLC Passive Investment

SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.10 CHEMOURS CO COMMON STOCK Cusip #163851108 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #163851108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 16,287,179 Item 6: 0 Item 7: 16,443,585 Item 8: 0 Item 9: 16,4

CC / The Chemours Company / BlackRock Inc. Passive Investment

SC 13G/A 1 us1638511089012324.txt us1638511089012324.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 12) CHEMOURS COMPANY - (Name of Issuer) Common Stock - (Title of Class of Securities) 163851108 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box

LETTER

United States securities and exchange commission logo January 10, 2024 Jonathan Lock Senior Vice President, Chief Financial Officer Chemours Co 1007 Market Street Wilmington, Delaware 19801 Re: Chemours Co Form 10-K for Fiscal Year ended December 31, 2022 File No.

* * *

January 8, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street N.

LETTER

United States securities and exchange commission logo January 3, 2024 Jonathan Lock Senior Vice President, Chief Financial Officer Chemours Co 1007 Market Street Wilmington, Delaware 19801 Re: Chemours Co Form 10-K for Fiscal Year ended December 31, 2022 Form 8-K Filed February 9, 2023 Response dated December 22, 2023 File No.

* * *

December 22, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street N.

LETTER

United States securities and exchange commission logo December 13, 2023 Jonathan Lock Senior Vice President, Chief Financial Officer Chemours Co 1007 Market Street Wilmington, Delaware 19801 Re: Chemours Co Form 10-K for Fiscal Year ended December 31, 2022 Form 10-Q for Fiscal Quarter Ended September 30, 2023 File No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 28, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 28, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

Chemours Announces Settlement Agreement with State of Ohio Agreement resolves the State's multiple PFAS-related claims.

EXHIBIT 99.1 Chemours Announces Settlement Agreement with State of Ohio Agreement resolves the State's multiple PFAS-related claims. Wilmington, Del., November 29, 2023 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announces that it, along

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 17, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 17, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

The Chemours Company Announces Changes to its Board of Directors Curtis Crawford retires from Board, Alister Cowan appointed director

EXHIBIT 99.1 The Chemours Company Announces Changes to its Board of Directors Curtis Crawford retires from Board, Alister Cowan appointed director Wilmington, Del., November 22, 2023 – The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announces two

Mine Safety Disclosures.

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as S

List of Guarantor Subsidiaries

Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of September 30, 2023, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4.

The Chemours Company Announces Third Quarter 2023 Results Continued actions through the Titanium Technologies Transformation Plan to drive improved margins FY 2023 Adjusted EBITDA guidance lowered 8% at the midpoint

EXHIBIT 99.1 The Chemours Company Announces Third Quarter 2023 Results Continued actions through the Titanium Technologies Transformation Plan to drive improved margins FY 2023 Adjusted EBITDA guidance lowered 8% at the midpoint Wilmington, Del., October 26, 2023 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Te

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 26, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 August 18, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of I

Amendment and Restatement Agreement, dated as of August 18, 2023, among The Chemours Company, the Lenders and Issuing Banks party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent. (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, as filed with the U.S. Securities and Exchange Commission on August 23, 2023).

EXHIBIT 10.1 EXECUTION VERSION AMENDMENT AND RESTATEMENT AGREEMENT dated as of August 18, 2023 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), the other LOAN PARTIES party hereto, the LENDERS and ISSUING BANKS party hereto and JPMORGAN CHASE BANK, N.A. (“JPMorgan”), as administrative agent (in such capacity, the “Administrative Agent”) under the Amended and

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 31, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc

Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million

EXHIBIT 99.1 Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million Wilmington, Del., August 1, 2023 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced it completed the sale of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specif

The Chemours Company Reports Second Quarter 2023 Results and Announces Closure of Titanium Dioxide Plant in Taiwan Solid second quarter despite signs of demand weakness, FY 2023 Adjusted EBITDA guidance lowered 9% at the midpoint

EXHIBIT 99.1 The Chemours Company Reports Second Quarter 2023 Results and Announces Closure of Titanium Dioxide Plant in Taiwan Solid second quarter despite signs of demand weakness, FY 2023 Adjusted EBITDA guidance lowered 9% at the midpoint Wilmington, Del., July 27, 2023 - The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 26, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 26, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc

Mine Safety Disclosures.

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

List of Guarantor Subsidiaries

Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of June 30, 2023, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 26, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 26, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc

Chemours Names Joseph Martinko as President, Thermal & Specialized Solutions New Leader Poised to Continue Delivering Strong Performance

EXHIBIT 99.1 Chemours Names Joseph Martinko as President, Thermal & Specialized Solutions New Leader Poised to Continue Delivering Strong Performance Wilmington, Del., July 26, 2023 – The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced th

Exhibit I – Excluded State-Owned Public Water Systems

EXHIBIT 10.1I EXHIBIT I: EXCLUDED STATE-OWNED PUBLIC WATER SYSTEMS PWS ID PWS Name Type Owner AR0000315 ADC - CUMMINS UNIT MAINT Community Water System State Government AS9711948 Central ASG Community Water System State Government AZ0407555 ASPC LEWIS COMPLEX WATER SYSTEM Community Water System State Government AZ0411705 ADOC EYMAN UNIT Community Water System State Government AZ0414099 ASPC YUMA C

Exhibit J – Excluded Federal-Owned Public Water Systems

EXHIBIT 10.1J EXHIBIT J: EXCLUDED FEDERAL-OWNED PUBLIC WATER SYSTEMS PWS ID PWS Name Type Owner AK2211423 JBER-ELMENDORF Community Water System Federal Government AK2370625 EIELSON - AIR FORCE BASE Community Water System Federal Government AK2372245 EIELSON - BIRCH LAKE RECREATION AREA Transient Non-Community Water System Federal Government AK2390594 DENALI - MAIN / FRONT COUNTRY Non-Transient Non

Exhibit D – Claims Forms

EXHIBIT 10.1D EXHIBIT D: CLAIMS FORMS Aqueous Film-Forming Foam (AFFF) Products Liability Litigation (MDL 2873) Public Water System Settlement Claims Form INSTRUCTIONS Please follow the instructions below to submit a claim for the AFFF Products Liability Litigation Settlement Program. A completed copy of this Claims Form must be submitted no later than the Claims Form Deadline. Late Claims Forms w

Exhibit G – Notice Plan

EXHIBIT 10.1G EXHIBIT G: NOTICE PLAN As detailed below, the Notice Plan provides for individual direct notice via USPS mail to all reasonably identifiable Settlement Class Members, outreach to national and local water organizations, a comprehensive media plan, and the implementation of a dedicated Settlement website and toll-free telephone line where Settlement Class Members can learn more about t

Exhibit L – Stipulation of Partial Dismissal With Prejudice

EXHIBIT 10.1L EXHIBIT L: STIPULATION OF PARTIAL DISMISSAL [CAPTION OF MDL MEMBER CASE OR OTHER LITIGATION] STIPULATION OF DISMISSAL OF RELEASED CLAIMS WITH PREJUDICE PURSUANT TO FEDERAL RULE OF CIVIL PROCEDURE 41(a)(1)(A)(ii) Pursuant to Rule 41(a)(1)(A)(ii) of the Federal Rules of Civil Procedure, Plaintiff in the above-captioned action and Defendants The Chemours Company, The Chemours Company FC

Exhibit K – Authorization Letter

EXHIBIT 10.1K EXHIBIT K: AUTHORIZATION LETTER [Letterhead of Settlement Class Member] [Date] [Claims Administrator], as Claims Administrator [Address] [Address] To the Claims Administrator: Reference is made to Paragraph 11.6.2 of the Class Action Settlement Agreement, dated as of June 30, 2023, by and among (i) Class Representatives, individually and on behalf of the Settlement Class Members, by

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 30, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 30, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inc

Exhibit B – Proposed Final Approval Order

EXHIBIT 10.1B Exhibit B: [Proposed] ORDER GRANTING FINAL APPROVAL UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION ) IN RE: AQUEOUS FILM-FORMING ) MDL No. 2:18-mn-2873 FOAMS PRODUCTS LIABILITY ) LITIGATION ) ) [PROPOSED] FINAL ORDER AND JUDGMENT APPROVING SETTLEMENT AGREEMENT Before the Court is the Motion of Class Counsel for Final Approval of Settlement Agreeme

Exhibit C – Allocation Procedures

EXHIBIT 10.1C EXHIBIT C: ALLOCATION PROCEDURES This Document describes the Allocation Procedures referred to in Section 11.5 of the Settlement Agreement. All capitalized terms not otherwise defined herein shall have the meanings set forth in the Settlement Agreement (which are included in the Definitions Annex attached hereto). The Court will appoint a Special Master and Claims Administrator pursu

Exhibit E – Notice

EXHIBIT 10.1E EXHIBIT E: NOTICE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION ) IN RE: AQUEOUS FILM-FORMING ) MDL No. 2:18-mn-02873 FOAMS PRODUCTS LIABILITY ) LITIGATION ) ) NOTICE OF PROPOSED CLASS ACTION SETTLEMENT AND COURT APPROVAL HEARING TO: All Public Water Systems in the United States of America that draw or otherwise collect from any Water Source that

Exhibit A – Proposed Preliminary Approval Order

EXHIBIT 10.1A Exhibit A: [Proposed] Order GRANTING PRELIMINARY APPROVAL UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION ) IN RE: AQUEOUS FILM-FORMING ) MDL No. 2:18-mn-2873 FOAMS PRODUCTS LIABILITY ) LITIGATION ) ) [PROPOSED] ORDER GRANTING PRELIMINARY APPROVAL OF Settlement AGREEMENT Before the Court is the Motion of proposed Class Counsel for Preliminary Appro

Settlement Agreement, dated June 30 2023, by and among The Chemours Company, The Chemours Company FC, LLC, DuPont de Nemours, Inc., Corteva Inc. and E. I. du Pont de Nemours and Company n/k/a EIDP, Inc. and representatives of certain U.S. public water systems as set out therein (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, as filed with the U.S. Securities and Exchange Commission on June 30, 2023).

EXHIBIT 10.1 EXECUTION COPY UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION ) IN RE: AQUEOUS FILM-FORMING ) MDL No. 2:18-mn-2873 FOAMS PRODUCTS LIABILITY ) LITIGATION ) ) CLASS ACTION Settlement Agreement This Settlement Agreement (including its Exhibits) is entered into, subject to Preliminary and Final Approval of the Court, as of June 30, 2023 (the “Settlemen

Exhibit H – Escrow Agreement

EXHIBIT 10.1H EXHIBIT H: ESCROW AGREEMENT CUSTODIAN/ESCROW AGREEMENT This Custodian/Escrow Agreement dated [●], 2023, is made among (i) The Chemours Company, The Chemours Company FC, LLC, DuPont de Nemours, Inc., Corteva, Inc., and E.I. DuPont de Nemours and Company n/k/a EIDP, Inc. (each a “Settling Defendant” and collectively, the “Settling Defendants”), (ii) Michael A. London and the law firm o

Exhibit F – Summary Notice

EXHIBIT 10.1F EXHIBIT F: SUMMARY NOTICE NOTICE OF PROPOSED CLASS ACTION SETTLEMENT AND COURT-APPROVAL HEARING In re: Aqueous Film-Forming Foams Product Liability Litigation, MDL No. 2:18-mn-02873 This Document relates to: City of Camden, et al., v. E.I. DuPont de Nemours and Company, et al., No. 2:23-cv-XXXX-RMG United States District Court, District of South Carolina, Charleston Division TO THE S

Sameer Ralhan Resigns as Chemours Chief Financial Officer (CFO); Company Appoints Jonathan Lock as new CFO and Promotes Matt Abbott to Executive Team as SVP, Chief Enterprise Transformation Officer

EXHIBIT 99.1 Sameer Ralhan Resigns as Chemours Chief Financial Officer (CFO); Company Appoints Jonathan Lock as new CFO and Promotes Matt Abbott to Executive Team as SVP, Chief Enterprise Transformation Officer Wilmington, Del., June 6, 2023 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solut

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 31, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco

Chemours, DuPont, and Corteva Reach Comprehensive PFAS Settlement with U.S. Water Systems

EXHIBIT 99.1 Chemours, DuPont, and Corteva Reach Comprehensive PFAS Settlement with U.S. Water Systems WILMINGTON, Del., June 2, 2023 – The Chemours Company (NYSE: CC), DuPont de Nemours, Inc. (NYSE: DD) and Corteva, Inc. (NYSE: CTVA) (the “companies”) today announced they have reached an agreement in principle to comprehensively resolve all PFAS-related drinking water claims of a defined class of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 1, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 1, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 1, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 1, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco

The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc. for $137 Million

EXHIBIT 99.1 The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc. for $137 Million WILMINGTON, Del., NASHVILLE, Tn, June 1, 2023 - The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials has entered int

Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD.

EX-1.01 2 cc-ex101.htm EX-1.01 Exhibit 1.01 CONFLICT MINERALS REPORT THE CHEMOURS COMPANY For the Reporting Period from January 1, 2022 to December 31, 2022 This Conflict Minerals Report (the “Report”) of The Chemours Company (“Chemours,” or the “Company”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) promulgated under the Securities and Exchange Act of 1934, as amended, for th

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report The Chemours Company (Exact Name of Registrant as Specified in Its Charter)

SD 1 cc-2023conflictmineral.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incorporation) File Number) Identification No.) 1007 Market Street Wilmington, Delaware

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 12, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 12, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of Inco

Chemours Thermal & Specialized Solutions President Resigns; Chemours Begins Talent Search for Backfill & Appoints Interim Leader Business strategies remain unchanged as Company begins search for new business leader

EXHIBIT 99.1 Chemours Thermal & Specialized Solutions President Resigns; Chemours Begins Talent Search for Backfill & Appoints Interim Leader Business strategies remain unchanged as Company begins search for new business leader WILMINGTON, Del.- MAY 18, 2023 (BUSINESS WIRE)- The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technolog

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Speci

List of Guarantor Subsidiaries

Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of March 31, 2023, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4.

Mine Safety Disclosures.

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

The Chemours Company Reports First Quarter 2023 Results Strong first quarter in Thermal & Specialized Solutions, company reaffirming full year 2023 Adjusted EBITDA and Free Cash Flow guidance

EXHIBIT 99.1 The Chemours Company Reports First Quarter 2023 Results Strong first quarter in Thermal & Specialized Solutions, company reaffirming full year 2023 Adjusted EBITDA and Free Cash Flow guidance Wilmington, Del., April 27, 2023 - The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (TT), Thermal & Specialized Solu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 26, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Compan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 26, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 27, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Compan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 April 27, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

CC / Chemours Company / FMR LLC Passive Investment

SCHEDULE 13G Amendment No.9 CHEMOURS CO COMMON STOCK Cusip #163851108 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #163851108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 15,105,986 Item 6: 0 Item 7: 15,256,878 Item 8: 0 Item 9: 15,256,878 Item 11: 10.252%

AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT Dated as of March 9, 2020 by and among THE CHEMOURS COMPANY AR, LLC, as Seller, THE PERSONS FROM TIME TO TIME PARTY HERETO, as Purchasers and as Group Agents, THE TORONTO-DOMINION BANK, as Administr

EXHIBIT 99.2 EXECUTION VERSION EXHIBIT A TO THE SECONDTHIRD AMENDMENT, DATED AS OF NOVEMBER 24MARCH 23, 20212023 AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT Dated as of March 9, 2020 by and among THE CHEMOURS COMPANY AR, LLC, as Seller, THE PERSONS FROM TIME TO TIME PARTY HERETO, as Purchasers and as Group Agents, THE TORONTO-DOMINION BANK, as Administrative Agent, THE TORONTO-DOMINION BAN

THIRD AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT

EXHIBIT 99.1 EXECUTION VERSION THIRD AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT This THIRD AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT (this “Amendment”), dated as of March 23, 2023, is among THE CHEMOURS COMPANY AR, LLC, as Seller (in such capacity, the “Seller”), THE CHEMOURS COMPANY FC, LLC (“Chemours”), as initial Servicer (in such capacity, the “Serv

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 23, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Compan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 23, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 22, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Compan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 22, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

Chemours Appoints Denise Dignam President, Titanium Technologies & Chemical Solutions, Gerardo Familiar Named President, Advanced Performance Materials Business strategies are unchanged as the company promotes top executives

EXHIBIT 99.1 Chemours Appoints Denise Dignam President, Titanium Technologies & Chemical Solutions, Gerardo Familiar Named President, Advanced Performance Materials Business strategies are unchanged as the company promotes top executives Wilmington, Del., March 23, 2023 – The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies

Chemours Titanium Technologies & Chemical Solutions Business President Resigns; Chemours Begins Talent Search for Backfill & Appoints Interim Leader Business strategies remain unchanged as Company begins search for new business leader

EXHIBIT 99.1 Chemours Titanium Technologies & Chemical Solutions Business President Resigns; Chemours Begins Talent Search for Backfill & Appoints Interim Leader Business strategies remain unchanged as Company begins search for new business leader WILMINGTON, Del., March 16, 2023 - The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Te

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 10, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Compan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 10, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

Amendment No. 2, dated as of March 10, 2023, to the Amended and Restated Credit Agreement, dated as of April 3, 2018, as amended, among The Chemours Company, the Lenders and Issuing Banks party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent.*

EXHIBIT 10.1 [EXECUTION VERSION] AMENDMENT NO. 2 dated as of March 10, 2023 (this “Amendment”), among THE CHEMOURS COMPANY, a Delaware corporation (the “Borrower”), and JPMORGAN CHASE BANK, N.A., as administrative agent (in such capacity, the “Administrative Agent”), to the Amended and Restated Credit Agreement dated as of April 3, 2018 (as amended, supplemented or otherwise modified from time to

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 10, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Compan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 10, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of In

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   ) Filed by the Registrant ☒Filed by a Party other than the Registra

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   ) Filed by the Registrant ☒Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   ) Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Def

ARS

Chemistry for a Sustainable Future THE CHEMOURS COMPANY 2022 | ANNUAL REPORTImportantly, we stepped up our focus on sustainable growth through announced investments in the hydrogen economy and lower global warming potential refrigerants, while redoubling our efforts in responsible manufacturing.

CC / Chemours Co / Sessa Capital (Master), L.P. Passive Investment

SC 13G/A 1 fp0082117-2sc13ga.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 3)* THE CHEMOURS COMPANY (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 163851108 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box t

Subsidiaries of the Registrant.

Exhibit 21 SUBSIDIARIES OF THE REGISTRANT Name Organized Under Laws Of 2463297 Ontario Limited Canada Chemours Belgium BVBA Belgium Chemours Chemicals Rus Russia Chemours Deutschland GmbH Germany Chemours France SAS France Chemours Hong Kong Holding Limited Hong Kong Chemours International Operations Sàrl Switzerland Chemours Italy S.

List of Guarantor Subsidiaries.

Exhibit 22 LIST OF GUARANTOR SUBSIDIARIES As of December 31, 2022, the following subsidiaries of The Chemours Company (the “Company”) were guarantors of the Company’s 4.

Mine Safety Disclosures.

Exhibit 95 MINE SAFETY DISCLOSURES The Company owns and operates a mineral sands mining and separation facility in Starke, Florida, mineral sands mining facilities in Jesup, Georgia and Nahunta, Georgia, and a mineral sands separation facility in Offerman, Georgia.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 February 9, 2023 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36794 46-4845564 (State or Other Jurisdiction (Commission (I.R.S. Employer Of